Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(60.0%)
N/A
2(40.0%)
5Total
Phase 4(3)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01245881Not ApplicableCompleted

Fractional Photothermolysis for Treating Melasma

Role: lead

NCT01052246Not ApplicableCompleted

Pulsed Dye Laser Treatment of Acne Vulgaris

Role: lead

NCT00994474Phase 4Completed

Comparison of Outcome Parameters in Laser Rhytide Treatment

Role: lead

NCT00990431Phase 4Completed

Ablative Fractional Lasers to Treat Peri-orbital Rhytides

Role: lead

NCT00434863Phase 4Completed

Comparative Study of the Effect of Dysport and Botox

Role: lead

All 5 trials loaded